Directors_NN
statements_NOMZ
of_PIN
responsibility_NOMZ
Directors_NN
statement_NOMZ
of_PIN
responsibility_NOMZ
in_PIN
relation_NOMZ
to_PIN
Internal_NN
control_NN
the_DT
consolidated_JJ
financial_JJ
statements_NOMZ
The_DT
Board_NN
,_,
through_PIN
the_DT
Audit_NN
Committee_NN
,_,
has_VPRT [PEAS]
reviewed_VBN
the_DT
The_DT
Directors_NN
are_VPRT [BEMA]
responsible_PRED
for_PIN
:_:
assessment_NOMZ
of_PIN
risks_NN
and_CC
the_DT
internal_JJ
control_NN
framework_NN
that_TSUB
operates_VPRT
in_PIN
GlaxoSmithKline_NN
and_CC
has_VPRT [PEAS]
considered_VBN [PRIV]
the_DT
effectiveness_NOMZ
of_PIN
the_DT
system_NN
ensuring_VBG [SUAV] [PRIV] [WZPRES]
the_DT
maintenance_NN
of_PIN
proper_JJ
accounting_GER
records_NN
,_,
which_WDT [SERE]
of_PIN
internal_JJ
control_NN
in_PIN
operation_NOMZ
in_PIN
the_DT
Group_NN
for_PIN
the_DT
year_NN
covered_VBN [WZPAST]
by_PIN
disclose_VB [PUBV]
with_PIN
reasonable_JJ
accuracy_NN
the_DT
financial_JJ
position_NOMZ
of_PIN
the_DT
Group_NN
this_DEMO
report_NN
and_CC
up_RB
to_PIN
the_DT
date_NN
of_PIN
its_PIT
approval_NN
by_PIN
the_DT
Board_NN
of_PIN
Directors_NN
._.
at_PIN
any_QUAN
time_NN
and_CC
from_PIN
which_WDT [PIRE]
financial_JJ
statements_NOMZ
can_POMD
be_VB [PASS]
prepared_VBN
to_TO
comply_VB
with_PIN
the_DT
Companies_NN
Act_NN
1985_CD
and_CC
Article_NN
4_CD
of_PIN
the_DT
IAS_NN
The_NN
Combined_NN
Code_NN
Regulation_NOMZ
The_NN
Board_NN
considers_VPRT [PRIV]
that_THVC
GlaxoSmithKline_NN
plc_NN
applies_VPRT
the_DT
principles_NN
of_PIN
preparing_VBG
financial_JJ
statements_NOMZ
for_PIN
each_QUAN
financial_JJ
period_NN
which_WDT [WHSUB]
give_VPRT
the_DT
Combined_NN
Code_NN
on_PIN
Corporate_NN
Governance_NN
of_PIN
the_DT
Financial_NN
a_DT
true_JJ
and_PHC
fair_JJ
view_NN
,_,
in_PIN
accordance_NN
with_PIN
IFRS_NN
as_IN
adopted_VBN
for_PIN
use_NN
in_PIN
Reporting_GER
Council_NN
,_,
as_IN
described_VBN
under_IN
Corporate_JJ
governance_NN
on_PIN
the_DT
European_NN
Union_NN
,_,
of_PIN
the_DT
state_NN
of_PIN
affairs_NN
of_PIN
the_DT
Group_NN
as_IN
at_PIN
the_DT
pages_NN
27_CD
to_PIN
36_CD
,_,
and_ANDC
has_VPRT [PEAS]
complied_VBN
with_PIN
its_PIT
provisions_NN
except_PIN
as_IN
end_NN
of_PIN
the_DT
financial_JJ
period_NN
and_CC
of_PIN
the_DT
profit_NN
or_CC
loss_NN
for_PIN
that_DEMO
period_NN
described_VBN [WZPAST]
on_PIN
pages_NN
35_CD
and_CC
36_CD
._.
ensuring_VBG [SUAV] [PRIV] [PRESP]
the_DT
operation_NOMZ
of_PIN
systems_NN
of_PIN
internal_JJ
control_NN
and_CC
for_PIN
taking_VBG
As_IN
required_VBN [SUAV]
by_PIN
the_DT
Listing_GER
Rules_NN
of_PIN
the_DT
Financial_NN
Services_NN
Authority_NOMZ
,_,
the_DT
reasonable_JJ
steps_NN
to_TO
safeguard_VB
the_DT
assets_NN
of_PIN
the_DT
Group_NN
and_CC
for_PIN
auditors_NN
have_VPRT [PEAS]
considered_VBN [PRIV]
the_DT
Directors_NN
statement_NOMZ
of_PIN
compliance_NN
in_PIN
preventing_VBG
and_PHC
detecting_VBG
fraud_NN
and_CC
other_JJ
irregularities_NOMZ
._.
relation_NOMZ
to_PIN
those_DEMO
points_NN
of_PIN
the_DT
Combined_NN
Code_NN
which_WDT [WHSUB]
are_VPRT [PASS]
specified_VBN
The_DT
financial_JJ
statements_NOMZ
for_PIN
the_DT
year_NN
ended_VBD
31st_CD
December_NN
2005_CD
,_,
for_PIN
their_TPP3
review_NN
._.
comprising_VBG
principal_JJ
statements_NOMZ
and_CC
supporting_VBG
notes_NN
,_,
are_VPRT [PASS]
set_VBN
out_PIN
in_PIN
Financial_NN
statements_NOMZ
on_PIN
pages_NN
84_CD
to_PIN
164_CD
of_PIN
this_DEMO
report_NN
._.
Annual_JJ
Report_NN
The_DT
Directors_NN
confirm_VPRT [PUBV]
that_THVC
suitable_JJ
accounting_GER
policies_NN
have_VPRT [PEAS]
been_VBN [BEMA]
The_DT
Annual_JJ
Report_NN
for_PIN
the_DT
year_NN
ended_VBD
31st_CD
December_NN
2005_CD
,_,
consistently_RB
applied_VBN
in_PIN
the_DT
preparation_NOMZ
of_PIN
the_DT
financial_JJ
statements_NOMZ
,_,
comprising_VBG [PRESP]
the_DT
Report_NN
of_PIN
the_DT
Directors_NN
,_,
the_DT
Remuneration_NOMZ
Report_NN
,_,
the_DT
supported_VBN
by_PIN
reasonable_JJ
and_PHC
prudent_JJ
judgements_NOMZ
and_PHC
estimates_NN
Financial_NN
statements_NOMZ
and_CC
additional_JJ
information_NOMZ
for_PIN
investors_NN
,_,
has_VPRT
as_RB
necessary_JJ
._.
been_VBN [BYPA]
approved_VBN
by_PIN
the_DT
Board_NN
of_PIN
Directors_NN
and_CC
signed_VBN
on_PIN
its_PIT
behalf_NN
by_PIN
The_DT
responsibilities_NOMZ
of_PIN
the_DT
auditors_NN
in_PIN
relation_NOMZ
to_PIN
the_DT
financial_JJ
statements_NOMZ
are_VPRT [PASS]
set_VBN
out_PIN
in_PIN
the_DT
Independent_NN
Auditors_NN
report_VPRT [PUBV]
page_NN
83_CD
opposite_PIN [STPR]
._.
The_DT
financial_JJ
statements_NOMZ
for_PIN
the_DT
year_NN
ended_VBD
31st_CD
December_NN
2005_CD
are_VPRT [PASS]
included_VBN
in_PIN
the_DT
Annual_JJ
Report_NN
2005_CD
,_,
which_WDT [SERE]
is_VPRT [PASS]
published_VBN
in_PIN
hard-copy_JJ
printed_VBN
form_NN
and_CC
made_VBN
available_JJ
on_PIN
the_DT
website_NN
._.
The_DT
Directors_NN
are_VPRT
Sir_NN
Christopher_NN
Gent_NN
responsible_JJ
for_PIN
the_DT
maintenance_NN
and_PHC
integrity_NOMZ
of_PIN
the_DT
Annual_JJ
Report_NN
Chairman_NN
on_PIN
the_DT
website_NN
in_PIN
accordance_NN
with_PIN
UK_NN
legislation_NOMZ
governing_VBG [WZPRES]
the_DT
1st_CD
March_NN
2006_CD
preparation_NOMZ
and_PHC
dissemination_NOMZ
of_PIN
financial_JJ
statements_NOMZ
._.
Access_NN
to_PIN
the_DT
website_NN
is_VPRT [BEMA]
available_PRED
from_PIN
outside_PLACE
the_DT
UK_NN
,_,
where_RB
comparable_JJ
legislation_NOMZ
may_POMD
be_VB [BEMA]
different_PRED
._.
Directors_NN
remuneration_VPRT
The_DT
Remuneration_NOMZ
Report_NN
on_PIN
pages_NN
37_CD
to_PIN
54_CD
sets_NN
out_PIN
the_DT
remuneration_NOMZ
policies_NN
operated_VBN [WZPAST]
by_PIN
GlaxoSmithKline_NN
and_PHC
disclosures_NN
on_PIN
Directors_NN
remuneration_NOMZ
and_CC
other_JJ
disclosable_JJ
information_NOMZ
relating_VBG [WZPRES]
to_PIN
Directors_NN
and_PHC
officers_NN
and_CC
their_TPP3
interests_NN
._.
It_PIT
has_VPRT [PEAS]
been_VBN [PASS]
prepared_VBN
in_PIN
accordance_NN
with_PIN
the_DT
Companies_NN
Act_NN
1985_CD
and_CC
complies_VPRT
with_PIN
Section_NOMZ
B_NN
of_PIN
the_DT
Combined_NN
Code_NN
on_PIN
Corporate_NN
Governance_NN
._.
Going_VBG
concern_NN
basis_NN
After_IN
making_VBG
enquiries_NN
,_,
the_DT
Directors_NN
have_VPRT
a_DT
reasonable_JJ
expectation_NOMZ
that_TOBJ
the_DT
Group_NN
has_VPRT
adequate_JJ
resources_NN
to_TO
continue_VB
in_PIN
operational_JJ
existence_NN
for_PIN
the_DT
foreseeable_JJ
future_NN
._.
For_PIN
this_DEMO
reason_NN
,_,
they_TPP3
continue_VPRT
to_TO
adopt_VB
the_DT
going_VBG
concern_NN
basis_NN
in_PIN
preparing_VBG
the_DT
financial_JJ
statements_NOMZ
._.
GSK_NN
Annual_JJ
Report_NN
2005_CD
82_CD
FINANCIAL_NN
STATEMENTS_NOMZ
